According to the latest report by IMARC Group “Wearable Injectors Market: Global Industry Trends, Size, Share, Growth, Opportunity and Forecast 2022-2027“, The global wearable injectors market reached a value of US$ 5.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 14.4 Billion by 2027, exhibiting a CAGR of 16.75% during 2022-2027.
Wearable injectors, sometimes known as patch pumps, are drug delivery devices that include a reservoir for storing medications, a cannula for delivering substances to tissues, and a motor mechanism for automatically providing preset doses to patients. They are pleasant and help to deliver viscous drugs in bigger volumes rapidly and securely through the body’s subcutaneous tissues. Wearable injectors, as opposed to traditional injections, are user-friendly, produce minimal pain, and are simple to dispose of.
Request for a free sample copy of this report: https://www.imarcgroup.com/wearable-injectors-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
One of the primary reasons positively influencing the market is the expanding senior population, which is more prone to chronic medical illnesses. In accordance with this, increased demand for minimally invasive (MI) treatment alternatives and increasing desire for home-based therapy among patients are two important factors contributing to the market’s favourable outlook. Furthermore, rising investment in healthcare infrastructure and services, as well as R&D activities, are expected to fuel the market.
Breakup by Type:
Breakup by Technology:
- Rotary Pump
- Expanding Battery
Breakup by Application:
- Infectious Diseases
- Cardiovascular Diseases
- Autoimmune Diseases
Breakup by End Use:
- Hospitals and Clinics
- Home Care
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Becton Dickinson and Company
- CeQur SA
- Debiotech SA
- Dexcom Inc.
- Enable Injections Inc.
- Gerresheimer AG
- Insulet Corporation
- Tandem Diabetes Care Inc.
- West Pharmaceutical Services Inc.
- Ypsomed AG.
Ask Analyst for Customization and Browse full report with TOC & List of Figure: https://www.imarcgroup.com/wearable-injectors-market
As the novel coronavirus (COVID-19) crisis takes over the world, we are continuously tracking the changes in the markets, as well as the industry behaviours of the consumers globally and our estimates about the latest market trends and forecasts are being done after considering the impact of this pandemic.
If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800